Biochemicals and Reagents

OBI-3424 is a research tool that is used to study receptor-ligand interactions. It can also be used to measure the effect of drugs on ion channels or protein interactions with receptors. OBI-3424 has a high purity and is used in pharmacology and cell biology research.

4-Methyl-N-[5-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-4-thiophen-2-yl-1,3-thiazol-2-yl]cyclohexane-1-carboxamide is a high purity drug. It is a potent inhibitor of voltage gated potassium channels that are responsible for the initiation and propagation of action potentials in excitable cells. 4MTC has been shown to inhibit the activity of neuronal ion channels by binding to their ligand sites. The protein target of 4MTC is not known, but it may be involved in cell growth and proliferation. This product can be used as a research tool or as an antibody to study the function of this protein.

(4aS,8aS,9S)-3-(Benzyloxy)-4a-((tert-butyldimethylsilyl)oxy)-9-(diethylamino)-8a,9-dihydronaphtho[2,3-d]isoxazole-4,5(4aH,8H)-dione is a potent inhibitor of protein interactions. It has been shown to inhibit the interaction between the receptor for peptide hormones and its ligand. The IC50 for this inhibition is less than 1 μM. This compound also has been used as a research tool to study protein interactions and as an antibody to measure ion channel activity.

Lats-in-1 is a potent inhibitor of the protein tyrosine phosphatase. This inhibitory effect is not due to its ability to bind to the catalytic site of the enzyme, but rather is due to its ability to bind to other regions of the protein that are not involved in catalysis. Lats-in-1 has been shown to bind selectively and specifically with high affinity and specificity to both recombinant and native proteins. Lats-in-1 has been used as a research tool for studying protein interactions, ligand binding and receptor activation.

(2R,3S)-1-(((2aR,4S,4aS,6R,9S,11S,12S,12bS)-12b-Acetoxy-12-(benzoyloxy)-4,6,11-trihydroxy-4a,8,13

Orexin receptor antagonist 2 is a peptide that binds to orexin receptors. It inhibits the activity of the orexin receptor and has no effect on other receptors. This compound is used as a research tool to study the function of the orexin receptor. Orexin receptor antagonist 2 can be used in conjunction with antibodies to study protein interactions, or with ligands to study ligand-receptor interactions. Applications include ion channels and neurotransmitter receptors.

TAK-448 is a peptide that inhibits the activation of ion channels. It binds to the ligand binding site of ion channels and blocks the passage of ions, thereby inhibiting the function of these proteins. TAK-448 has been shown to inhibit potassium, calcium, and sodium channels in vitro. This inhibitor also has an antagonist effect on GABA-A receptors in vivo. TAK-448 is a reagent for research in cell biology, pharmacology, and other fields. It can be used as a standard tool to study protein interactions or as an activator for receptor studies. TAK-448 is provided at high purity (greater than 99%) with no detectable contaminants.

Fenbendazole-amine sulfoxide is a research tool that acts as an activator or ligand for receptor. It is a high-purity reagent for use in pharmacology and cell biology research. Fenbendazole-amine sulfoxide is used to study the function of ion channels and receptors, and its effects on antibody production. Fenbendazole-amine sulfoxide has been shown to inhibit the activity of protein interactions, which may be due to its inhibition of peptide binding or protein synthesis.

BDP-13176 is a peptide used as a research tool. It binds to the beta-adrenergic receptor and activates it. BDP-13176 is a high purity product with an ionic charge of -1. It has been shown to inhibit the activity of ion channels, such as voltage-gated calcium channels in neuroblastoma cells. This product also inhibits ligand binding to the beta-adrenergic receptor, which may be due to its ability to compete with endogenous ligands for binding site on the receptor. BDP-13176 is a potent activator of the beta-adrenergic receptor, with an EC50 of 6 nM in rat heart cells.

KF 13218 is a research tool that is used as an activator to study the effects of ion channels on cell function. It binds to receptor sites and regulates the flow of ions through ion channels, which are protein structures that allow the passage of charged particles. KF 13218 has an affinity for ligand-gated ion channels, such as nicotinic acetylcholine receptors and serotonin 5HT3 receptors. This drug also has been shown to inhibit the activity of potassium channels in human neutrophils.

Dolutegravir is a non-nucleoside reverse transcriptase inhibitor that is used in the treatment of HIV. It is a competitive inhibitor of HIV-1 integrase and blocks HIV-1 replication by inhibiting the integration of viral DNA into the host cell genome. Dolutegravir binds to a specific region on the integrase protein, which prevents it from interacting with its target DNA sequence. This binding inhibits the incorporation of viral DNA into host cells, resulting in inhibition of viral replication. Dolutegravir also has been shown to have agonist activity at the human histamine H3 receptor and has potential as an anti-inflammatory agent.

Ascaroside C9 is a research tool that is used to activate, bind and/or inhibit ion channels. It has been shown to act as an inhibitor of voltage-gated potassium channels, which are required for the transmission of nerve impulses. Ascaroside C9 has also been shown to activate and inhibit ligand-gated ion channels, such as nicotinic acetylcholine receptors.

Rebamipide is a peptide that activates the receptor GPR18. It has been shown to inhibit ion channels and ligand-gated ion channels. This drug also has an affinity for the antibody Fc gamma RIIIa binding site, which may be due to its ability to inhibit the activity of T lymphocytes. Rebamipide binds to cell membrane receptors and inhibits the release of proinflammatory cytokines such as IL-6, IL-8, and TNF-α.

Quisinostat is a drug that belongs to the group of protein inhibitors. It inhibits the activity of histone deacetylases (HDACs), which are enzymes that remove acetyl groups from lysine residues on histones and other proteins. Quisinostat can inhibit HDACs by binding to a zinc atom in the active site of these enzymes. This inhibition disrupts the transcriptional regulation of genes, leading to cell death. Quisinostat has been shown to have anti-tumor effects in animal models and is being investigated for potential use in cancer treatment.

Pseudocoptisine chloride is a peptide that has been shown to be an inhibitor of protein interactions. This molecule also has the ability to activate receptors and ion channels; it is a ligand of the nicotinic acetylcholine receptor and a reagent used in research on protein interactions. Pseudocoptisine chloride is available as a high-purity liquid in vials of 1 mL.

2-Propenoic acid is a high purity, research tool that is an activator and ligand for the receptor. It is used in Cell Biology as an antibody to study protein interactions, and as a pharmacological agent in peptides. 2-Propenoic acid has been shown to inhibit ion channels, which may be due to its ability to block the binding of ions to specific sites on the channel protein. This product has also been shown to be a potent inhibitor of the enzyme phosphodiesterase 4 (PDE4), which is involved in signal transduction pathways that regulate cellular proliferation and differentiation.

BAY8040 is a research tool that has been shown to activate receptors and ion channels. It binds to cell surfaces and can be used in the study of protein interactions. BAY8040 is a ligand that binds to the receptor, which is an enzyme found on the surface of cells. BAY8040 can also be used as a pharmacological agent for the treatment of high blood pressure, inflammation, or pain.

Il-4 is a cytokine that plays an important role in the immune system. Il-4 inhibitor is a research tool that can be used to study the function of this cytokine. It has been shown to activate and bind to the IL-4 receptor, which is found on many cells, including eosinophils, basophils, monocytes, and lymphocytes. Il-4 inhibitor binds to these receptors as a ligand while inhibiting the effects of IL-4 by binding to its receptor. The IL-4 inhibitor also inhibits the activity of certain ion channels and prevents high levels of calcium ions from entering cells. The il-4 inhibitor has been shown to inhibit protein interactions and interfere with peptide synthesis. This compound is CAS No. 1332184-63-0 and can be used for life science research or pharmacology studies.

Pasireotide pamoate is a peptide that is known to interact with ion channels, receptors, and ligands. It has been shown to activate some of these proteins and inhibit others. Pasireotide pamoate can be used as a research tool in the study of protein interactions, especially those that are involved in cell biology. Pasireotide pamoate binds to antibodies and has been shown to inhibit the activity of certain enzymes. It is also an inhibitor of cellular activation at high concentrations.

Tmbim6 antagonist-1 is a peptide that belongs to the ligand class of antagonists. It blocks the activity of the TMBIM6 receptor, which is found in cells of the immune system and is important for regulating inflammation. Tmbim6 antagonist-1 has been shown to inhibit the activation of ion channels and can be used as a research tool in cell biology.